参考:
[1] 上海华颜医药科技有限公司. `Patent No`..31236 上海汉声知识产权代理有限公司
[2] Tsuchiya, A., Takeuchi, S., Watanabe, T., Yoshida, T., Nojiri, S., Ogawa, M., & Terai, S. (2019). Mesenchymal stem cell therapies for liver cirrhosis: MSCs as 'conducting cells' for improvement of liver fibrosis and regeneration. Inflammation and regeneration, 39, 18. https:///10.1186/s41232-019-0107-z
[3] Xie, Baocheng & Chen, Minyi & Hu, Runkai & Han, Weichao & Ding, Shaobo. (2020). Therapeutic Evidence of Human Mesenchymal Stem Cell Transplantation for Cerebral Palsy: A Meta-Analysis of Randomized Controlled Trials. Stem Cells International. 2020. 1-10. 10.1155/2020/5701920.
[4] Meng, M., Liu, Y., Wang, W., Wei, C., Liu, F., Du, Z., Xie, Y., Tang, W., Hou, Z., & Li, Q. (2018). Umbilical cord mesenchymal stem cell transplantation in the treatment of multiple sclerosis. American journal of translational research, 10(1), 212–223.
[5] 王佃亮.(2020).脐带间充质干细胞制剂的质量管理及有效性和安全性.转化医学杂志,65-69.
[6] Liang, Jun & Zhang, Huayong & Kong, Wei & Deng, Wei & Wang, Dandan & Feng, Xuebing & Zhao, Cheng & Hua, Bingzhu & Wang, Hong & Sun, Lingyun. (2018). Safety analysis in patients with autoimmune disease receiving allogeneic mesenchymal stem cells infusion: a long-term retrospective study. Stem Cell Research & Therapy. 9. 10.1186/s13287-018-1053-4.
[7] Feng, X., Pan, W., Liu, L., Wu, M., Ding, F., Hu, H., Ding, X., Wei, H., Zou, Y., Qian, X., Wang, M., Wu, J., Tao, J., Tan, J., Da, Z., Zhang, M., Li, J., Sun, L., & Jiangsu Lupus Collaborative Group (2016). Prognosis for Hospitalized Patients with Systemic Lupus Erythematosus in China: 5-Year Update of the Jiangsu Cohort. PloS one, 11(12), e0168619. https:///10.1371/journal.pone.0168619
[8] Kang, W. C., Oh, P. C., Lee, K., Ahn, T., & Byun, K. (2016). Increasing injection frequency enhances the survival of injected bone marrow derived mesenchymal stem cells in a critical limb ischemia animal model. The Korean journal of physiology & pharmacology : official journal of the Korean Physiological Society and the Korean Society of Pharmacology, 20(6), 657–667. https:///10.4196/kjpp.2016.20.6.657
[9] Lamo-Espinosa, J. M., Mora, G., Blanco, J. F., Granero-Moltó, F., Nú?ez-Córdoba, J. M., López-Elío, S., Andreu, E., Sánchez-Guijo, F., Aquerreta, J. D., Bondía, J. M., Valentí-Azcárate, A., Del Consuelo Del Ca?izo, M., Villarón, E. M., Valentí-Nin, J. R., & Prósper, F. (2018). Intra-articular injection of two different doses of autologous bone marrow mesenchymal stem cells versus hyaluronic acid in the treatment of knee osteoarthritis: long-term follow up of a multicenter randomized controlled clinical trial (phase I/II). Journal of translational medicine, 16(1), 213. https:///10.1186/s12967-018-1591-7
[10] 张学峰,张美荣,胡建霞,王丽,张桂芝,邵磊,李晟刚,高宏,苗志敏,王颜刚.(2010).异种脐带间充质干细胞静脉应用的安全性.中国组织工程研究与临床康复,93-97.doi:CNKI:SUN:XDKF.0.2010-32-029.
[11] 田义超,周端鹏,崔艳君,张亚奇,刘梦杰,饶巍,张权,方攀,庞聪,岑玉杰,韩兵,武栋成.(2019).人脐带间充质干细胞的安全性毒理学评价.中国新药杂志,28(02),35-39.doi:CNKI:SUN:ZXYZ.0.2019-02-006.
[12] 王慧娜,杜丽欣,宋亚昆,杨志刚,刘兵,吴东颖,吕双红.(2015).人脐带间充质干细胞体内移植的安全性研究.生物技术通讯,91-93.doi:生物技术通讯.
[13] 李改兰, 阎新龙, 高娇, 史高娜, & 范祖森. (2014). 间充质干细胞与肿瘤转移. 生物技术通讯, 25(002), 279-281.
[14] Zhu, Wei & Huang, Ling & Li, Yahong & Qian, Hui & Shan, Xiu-hong & Yan, Yongmin & Mao, Fei & Wu, Xiaosheng & Xu, Wen-Rong. (2011). Mesenchymal stem cell-secreted soluble signaling molecules potentiate tumor growth. Cell cycle (Georgetown, Tex.). 10. 3198-207. 10.4161/cc.10.18.17638.
[15] Breitbach, Martin & Bostani, Toktam & Roell, Wilhelm & Xia, Ying & Dewald, Oliver & Nygren, Jens & Fries, Jochen & Tiemann, Klaus & Bohlen, Heribert & Hescheler, Jürgen & Welz, Armin & Bloch, Wilhelm & Jacobsen, Sten & Fleischmann, Bernd. (2007). Potential risks of bone marrow cell transplantation into infarcted hearts. Blood. 110. 1362-9. 10.1182/blood-2006-12-063412.
[16] 张蕾,冯文静,高宏,胡松,张敏,毛拥军.(2017).脐带间充质干细胞对衰老心肌细胞炎症因子表达影响.青岛大学医学院学报(02),31-34.doi:10.13361/j.qdyxy.201702009.